Mount Sinai researchers advanced universal influenza virus vaccine
On Dec. 7, 2020, an universal influenza virus vaccine, which produces antibodies that target the part of the…
FDA authorized first COVID-19 and flu combination test for use with home-collected samples
On Dec. 4, 2020, the FDA authorized the first diagnostic test for at home collection of patient samples…
High-dose influenza vaccine showed no additional benefit for heart disease patients
On Dec. 4, 2020, it was reported in JAMA that high-dose influenza (commonly known as flu) vaccines are…
Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected person
On Nov. 24, 2020, Roche announced that the FDA had approved a supplemental New Drug Application for Xofluzaï¾®…
FDA expanded approval of influenza treatment to post-exposure prevention
On Nov. 23, 2020, the FDA expanded the approved indication for Genentech’s Xofluza (baloxavir marboxil) to include post-exposure…
Genentech announced FDA Approval of Xofluza for prevention of influenza following contact with infected person
On Nov. 23, 2020, Genentech announced that the FDA had approved a supplemental New Drug Application (sNDA) for…
XBiotech data showed effective anti-virus activity for antibodies in candidate influenza-COVID-19 therapeutic
On Nov. 19, 2020, XBiotech announced data for its breakthrough candidate therapy for treating infections of influenza and…
Celdara Medical secured funding to develop an adjuvanted universal flu vaccine
On Nov. 17, 2020, Celdara Medical announced that the NIH had awarded a two-year Small Business Innovation Research…
Aegis Sciences launched combined test for SARS-CoV-2 and influenza A/B virus
On Nov. 16, 2020, Aegis Sciences announced that it had launched a combined test for SARS-CoV-2 and influenza…
CHMP recommended EU approval of Rocheï¾’s Xofluzaï¾® (baloxavir marboxil) for the treatment of influenza
On Nov. 13, 2020, Roche announced that the European Medicines Agencyï¾’s (EMA) Committee for Medicinal Products for Human…
Mesa Biotech received additional $13 million from HHS to develop 30 minute SARS-CoV-2 & Flu A/Flu B test
On Nov. 6, 2020, Mesa Biotech announced it had been awarded a contract up to $13 million from…
Novavax announced facility expansion to support global vaccine development
On Oct. 30, 2020, Novavax announced the expansion of its Maryland campus to accommodate the companyï¾’s rapid growth…
PerkinElmer received CE Mark for multi-analyte respiratory panel including COVID-19
On Oct. 26, 2020, PerkinElmer announced that its PKampï¾™ Respiratory SARS-CoV-2 RT-PCR Panel had received clearance to be…
OPKO Health’s BioReference Laboratories launched multiplex COVID-19 and influenza A/B test
On Oct. 20, 2020, BioReference Laboratories, an OPKO Health company, announced that it was accepting specimens for a…
University of Oxford scientists developed extremely rapid diagnostic test for Covid-19
On Oct. 15, 2020, scientists from the University of Oxford ï¾’s Department of Physics announced they had developed…
Vaxxas announced $22 million award from U.S. Government to advance Vaxxas Needle-Free HD-MAPï¾™ vaccine patch
On Oct. 5, 2020, Vaxxas announced a $22 million United States government award to support the deployment of…
Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the FDA to market…
Quest Diagnostics launched three new combined COVID-19 and respiratory virus tests
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
BD announced CE Mark of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
XBiotech to develop human antibody combination as candidate treatment for influenza-COVID-19 co-infection
On Sept. 21, 2020, XBiotech announced it was developing a new breakthrough candidate therapy it calls FLUVIDï¾™ for…
Sanofi and GSK confirmed agreement with European Union to supply up to 300 million doses of adjuvanted COVID-19 vaccine
On Sept. 18, 2020, Sanofi and GSK finalised and signed an advanced purchase agreement with the European Commission…
Vaxess Technologies to develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
Flu may increase the spread of Covid-19
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…
The ACIP updated flu vaccine recommendations for 2020-2021
On Sept. 9, 2020, the AAFP reviewed and agreed with the Advisory Committee on Immunization Practices’ recommendations for…
LabCorp launched first combined test for Covid-19, flu and RSV in time for flu season
On Sept. 8, 2020, LabCorpï¾® announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
DiaSorin Molecular received FDA clearance for the Simplexaï¾™ flu A/B & RSV direct gen II assay Simplexaï¾™ Flu A/B & RSV Direct Gen II Assay
On Sept. 8, 2020, DiaSorin Molecular announced that it had received FDA Clearance for its Simplexaï¾™ Flu A/B…
Sanofi and GSK initiated Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
On Sept. 3, 2020, Sanofi and GSK announced the start of the Phase 1/2 clinical trial for their…
US Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Srategic National Stockpile
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
Janssen discontinued Pimodivir influenza development program
On Sept. 2, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that it had made a…
NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…